The DOI matches its Crossref record; 296 of the 296 references it cites were found in a registry or an index.
Alzheimer Disease
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–296 of 296
DIPATRE, P. L., & GELMAN, B. B. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199702000-00004 · Cited by 157
Cholinesterase inhibitors increase secretion of APPs in rat brain cortex
Mori, F., Lai, C.-C., Fusi, F., & Giacobini, E. (1995) · Neuroreport · doi:10.1097/00001756-199503000-00012 · Cited by 157
Ikeda, S., Allsop, D., & Glenner, G. G. (1989) · PubMed · Cited by 156
Butler, S. M., Ashford, J. W., & Snowdon, D. A. (1996) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1996.tb01831.x · Cited by 154
Allsop, D., Landon, M., Kidd, M., Lowe, J. S., Reynolds, G. P., & Gardner, A. (1986) · Neuroscience Letters · doi:10.1016/0304-3940(86)90152-7 · Cited by 145
YAMAGUCHI, H., Nakazato, Y., Hirai, S., Shoji, M., & Harigaya, Y. (1989) · Europe PMC (PubMed Central) · Cited by 143
Rheumatold Arthritis and Senile Dementia of the Alzhelmer's Type
Jenkinson, M. L., Bliss, M. R., BRAIN, A. T., & Scott, D. L. (1989) · Lara D. Veeken · doi:10.1093/rheumatology/28.1.86-b · Cited by 143
Neuropathology of Alzheimer disease: pathognomonic but not pathogenic
Castellani, R. J., Lee, H., Zhu, X., Nunomura, A., Perry, G. L., & Smith, M. A. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0071-y · Cited by 141
Self-citationHirano Body Filaments Contain Actin and Actin-Associated Proteins
Galloway, P. G., Perry, G. L., & Gambetti, P. L. (1987) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-198703000-00006 · Cited by 140
Beard, C. M., Kokmen, E., Offord, K. P., & Kurland, L. T. (1992) · Neurology · doi:10.1212/wnl.42.11.2063 · Cited by 137
Rudelli, R. D., Ambler, M. W., & Wísniewski, H. M. (1984) · Acta Neuropathologica · doi:10.1007/bf00690393 · Cited by 136
Alzheimer's disease: A conceptual history
Berríos, G. E. (1990) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.930050603 · Cited by 136
A FATAL ENCEPHALOPATHY IN CHRONIC HÆMODIALYSIS PATIENTS
BURKS, J. S., Huddlestone, J., Alfrey, A. C., Norenberg, M., & Lewin, E. B. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91608-1 · Cited by 136
Winblad, B., Grossberg, G., Frölich, L., Farlow, M., Zechner, S., Nagel, J., & Lane, R. (2007) · Neurology · doi:10.1212/01.wnl.0000281847.17519.e0 · Cited by 136
The topography of cell loss from locus caeruleus in Alzheimer's disease
Marcyniuk, B., Mann, D. M. A., & Yates, P. O. (1986) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(86)90179-6 · Cited by 135
Incidence of cerebrovascular lesions in Alzheimer's disease: a postmortem study
Jellinger, K. A., & Attems, J. (2003) · Acta Neuropathologica · doi:10.1007/s00401-002-0634-5 · Cited by 133
Impact of Alzheimer's pathology on cognitive trajectories in nondemented elderly
Driscoll, I., Resnick, S. M., Troncoso, J. C., An, Y., O'Brien, R., & Zonderman, A. B. (2006) · Annals of Neurology · doi:10.1002/ana.21031 · Cited by 132
Rodgers‐Johnson, P., Garruto, R. M., Yanagihara, R. T., Chen, K.-M., Gajdusek, D. C., & Gibbs, C. J. (1986) · Neurology · doi:10.1212/wnl.36.1.7 · Cited by 132
Economic considerations in the management of Alzheimer's disease
Zhu, C. W., & Sano, M. (2006) · Clinical Interventions in Aging · doi:10.2147/ciia.2006.1.2.143 · Cited by 129
The isolation and amino acid composition of senile plaque core protein
Allsop, D., Landon, M., & Kidd, M. (1983) · Brain Research · doi:10.1016/0006-8993(83)91273-8 · Cited by 128
A special type of senile plaque, possibly an initial stage
Probst, A., Brunnschweiler, H., Lautenschläger, C., & ULRICH, J. (1987) · Acta Neuropathologica · doi:10.1007/bf00692843 · Cited by 127
Increases in luteinizing hormone are associated with declines in cognitive performance
Casadesús, G., Milliken, E. L., Webber, K. M., Bowen, R. L., Lei, Z. M., Rao, C. V., Perry, G. L., Keri, R. A., & Smith, M. A. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2006.06.013 · Cited by 127
Self-citationCholinesterase Inhibitors Stabilize Alzheimer's Disease
Giacobini, E. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06942.x · Cited by 123
The PreA4695precursor protein of Alzheimer's disease A4 amyloid is encoded by 16 exons
Lemaire, H.-G., Salbaum, J. M., Multhaup, G., Kang, J., Bayney, R. M., Unterbeck, A., Beyreuther, K. T., & Müller‐Hill, B. (1989) · Nucleic Acids Research · doi:10.1093/nar/17.2.517 · Cited by 122
Conner, J. M., Darracq, M. A., Roberts, J., & Tuszynski, M. H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1941 · Cited by 116
Contribution of redox-active iron and copper to oxidative damage in Alzheimer disease
Castellani, R. J., Honda, K., Zhu, X., Cash, A., Nunomura, A., Perry, G. L., & Smith, M. A. (2004) · Ageing Research Reviews · doi:10.1016/j.arr.2004.01.002 · Cited by 112
Self-citationTuszynski, M. H., & Gage, F. H. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.10.4621 · Cited by 110
Zajaczkowski, W., Quack, G., & Danysz, W. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00716-4 · Cited by 110
In vivo mapping of amyloid toxicity in Alzheimer disease
Frisoni, G. B., Lorenzi, M., Caroli, A., Kemppainen, N. M., Någren, K., & Rinne, J. O. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a2e896 · Cited by 108
Age and Histopathologic Heterogeneity in Alzheimer's Disease: Evidence for Subtypes
Bondareff, W., Mountjoy, C. Q., Roth, M., Rossor, M. N., Iversen, L. L., & Reynolds, G. P. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800170026005 · Cited by 105
Misztal, M., Frankiewicz, T., Parsons, C. G., & Danysz, W. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00682-6 · Cited by 103
Long-term stabilizing effect of cholinesterase inhibitors in the therapy of Alzheimer’ disease
Giacobini, E. (2002) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6139-5_17 · Cited by 100
Congophilic microangiopathy in the pathogenesis of Alzheimer's syndrome (presenile dementia)
Glenner, G. G. (1979) · Medical Hypotheses · doi:10.1016/0306-9877(79)90005-7 · Cited by 100
Nerve Growth Factor Gene Therapy in Alzheimer Disease
Tuszynski, M. H. (2007) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e318068d6d2 · Cited by 99
Dopaminergic neurotransmitter systems in Alzheimer's disease and in Down's syndrome at middle age.
Mann, D. M. A., Yates, P. O., & Marcyniuk, B. (1987) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.50.3.341 · Cited by 98
Praprotnik, D., Smith, M. A., Richey, P. L., Vinters, H. V., & Perry, G. L. (1996) · Acta Neuropathologica · doi:10.1007/s004010050420 · Cited by 97
Self-citationEducation and Occupation as Risk Factors for Dementia: A Population-Based Case-Control Study
Bonaiuto, S., Rocca, W. A., Lippi†, A., Giannandrea, E., Mele, M., Cavarzeran, F., & Amaducci, L. A. (1995) · Neuroepidemiology · doi:10.1159/000109785 · Cited by 94
Asuni, A. A., Boutajangout, A., Scholtzova, H., Knudsen, E., Li, Y. S., Quartermain, D., Frangione, B., Wısnıewskı, T., & Sigurdsson, E. M. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.05149.x · Cited by 93
Comparison of Aβ levels in the brain of familial and sporadic Alzheimer's disease
Hellström‐Lindahl, E., Viitanen, M. H., & Marutle, A. (2009) · Neurochemistry International · doi:10.1016/j.neuint.2009.03.007 · Cited by 89
Higgins, L. S., Murphy, G. M., Forno, L. S., Catalano, R., & Cordell, B. (1996) · Europe PMC (PubMed Central) · Cited by 88
Yamada, T., Sasaki, H., Doh-ura, K., Goto, I., & Sakaki, Y. (1989) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1016/0006-291x(89)92808-8 · Cited by 88
Klein, R. L., Hirko, A. C., Meyers, C., Grimes, J. R., Muzyczka, N., & Meyer, E. M. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02634-2 · Cited by 87
Oxidative damage in the olfactory system in Alzheimer's disease
Perry, G. L., Castellani, R. J., Smith, M. A., Harris, P. L. R., Kubat, Z., Ghanbari, K., Jones, P. K., Cordone, G., Tabaton, M., Wolozin, B. L., et al. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0761-7 · Cited by 81
Self-citationLoss of muscarinic M4 receptors in hippocampus of Alzheimer patients
Mulugeta, E., Karlsson, E., Islam, A., Kalaria, R. N., Mangat, H. S., Winblad, B. G., & Adem, A. (2003) · Brain Research · doi:10.1016/s0006-8993(02)03542-4 · Cited by 80
Do Cholinesterase Inhibitors Have Disease-Modifying Effects in Alzheimer??s Disease?
Giacobini, E. (2001) · CNS Drugs · doi:10.2165/00023210-200115020-00001 · Cited by 78
A4 amyloid protein immunoreactivity is present in Alzheimer's disease neurofibrillary tangles
Hyman, B. T., Hoesen, G. W. V., Beyreuther, K. T., & Masters, C. L. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90559-4 · Cited by 74
Nikolic, W. V., Bai, Y., Obregon, D. F., Hou, H., Mori, T., Zeng, J., Ehrhart, J. C., Shytle, R. D., Giunta, B. N., Morgan, D., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609377104 · Cited by 74
AMYLOID PRECURSOR PROTEIN IN SENILE PLAQUES OF ALZHEIMER DISEASE
Perry, G. L., Lipphardt, S., Kancherla, M., Gambetti, P. L., Maggiora, L. L., Lobl, T. J., Mulvihill, P., Mijares, M., Sharma, S. K., Cornette, J. C., et al. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90219-x · Cited by 74
The Immunopathology of Alzheimer's Disease and Some Related Disorders
Kalaria, R. N. (1993) · Brain Pathology · doi:10.1111/j.1750-3639.1993.tb00761.x · Cited by 72
Pardridge, W. M., Vinters, H. V., Yang, J., Eisenberg, J., Choi, T. B., Tourtellotte, W. W., Huebner, V. D., & Shively, J. E. (1987) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1987.tb01005.x · Cited by 68
Mann, D. M. A., & Jones, D. (1990) · Neuroscience Letters · doi:10.1016/0304-3940(90)90539-l · Cited by 68
Pathological changes in frontal cortex from biopsy to autopsy in Alzheimer's disease
Bennett, D. A., Cochran, E. J., Saper, C. B., Leverenz, J. B., Gilley, D. W., & Wilson, R. S. (1993) · Neurobiology of Aging · doi:10.1016/0197-4580(93)90043-b · Cited by 67
Holtzman, D. M., Li, Y., Chen, K., Gage, F. H., Epstein, C. J., & Mobley, W. C. (1993) · Neurology · doi:10.1212/wnl.43.12.2668 · Cited by 67
Regulated lentiviral NGF gene transfer controls rescue of medial septal cholinergic neurons
Blesch, A., Conner, J. M., Pfeifer, A., Gasmi, M., Ramirez, A., Britton, W. R., Alfa, R. W., Verma, I. M., & Tuszynski, M. H. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.01.007 · Cited by 66
Immunocytochemical properties of Alzheimer straight filaments
Perry, G. L., Mulvihill, P., Manetto, V., AUTILIO‐GAMBETTI, L., & Gambetti, P. (1987) · Journal of Neuroscience · doi:10.1523/jneurosci.07-11-03736.1987 · Cited by 66
Smith, M. A., Siedlak, S. L., Richey, P. L., Nagaraj, R. H., Elhammer, Å. P., & Perry, G. L. (1996) · Brain Research · doi:10.1016/0006-8993(95)01473-x · Cited by 65
Self-citationPro, J. D. Z., Smith, M. C. H., & Sumi, S. M. (1980) · Neurology · doi:10.1212/wnl.30.8.820 · Cited by 64
Self-citationPharmacologic treatment of cognition in Alzheimer's dementia
Farlow, M. R., & Evans, R. M. (1998) · Neurology · doi:10.1212/wnl.51.1_suppl_1.s36 · Cited by 64
Cholinergic therapy in dementia
Whitehouse, P. J. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1993.tb04254.x · Cited by 63
Brooks, W. S., Kwok, J. B. J., Kril, J. J., Broe, G. A., Blumbergs, P. C., Tannenberg, A. E. G., Lamont, P. J., Hedges, P., & Schofield, P. R. (2003) · Brain · doi:10.1093/brain/awg084 · Cited by 62
Evidence of amyloid beta-protein immunoreactive early plaque lesions in Down's syndrome brains.
Ikeda, S., Yanagisawa, N., Allsop, D., & Glenner, G. G. (1989) · PubMed · Cited by 61
Kidd, M., Allsop, D., & Landon, M. (1985) · The Lancet · doi:10.1016/s0140-6736(85)91054-2 · Cited by 60
Roth, M., Tomlinson, B. E., & Blessed, G. (1967) · PubMed · Cited by 59
Castellani, R. J., Smith, M. A., Perry, G., & Friedland, R. P. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.12.019 · Cited by 57
Self-citationAlzheimer’s Disease and Cellular Aging: Membrane-Related Events as Clues to Primary Mechanisms
Bosman, G. J. C. G. M., Bartholomeus, I. G. P., & Grip, W. J. D. (2009) · Gerontology · doi:10.1159/000213253 · Cited by 57
Sequestration of Tubulin in Neurons in Alzheimer's disease
Price, D. L., Altschuler, R. J., Struble, R. G., Casanova, M. F., Cork, L. C., & Murphy, D. B. (1986) · Brain Research · doi:10.1016/0006-8993(86)91077-2 · Cited by 55
The effects of mitochondrial failure upon cholinergic toxicity in the nucleus basalis
Wenk, G. L., Danysz, W., & Roice, D. (1996) · Neuroreport · doi:10.1097/00001756-199606170-00001 · Cited by 54
Chitin-like Polysaccharides in Alzheimers Disease Brains
Castellani, R., Siedlak, S., Fortino, A., Perry, G., Ghetti, B., & Smith, M. (2005) · Current Alzheimer Research · doi:10.2174/156720505774330555 · Cited by 52
Self-citationTwisted ribbon structure of paired helical filaments revealed by atomic force microscopy
Pollanen, M. S., Markiewicz, P., Bergeron, C., & Goh, M. C. (1994) · Neurobiology of Aging · doi:10.1016/0197-4580(94)92536-4 · Cited by 51
Estrogen Bows to a New Master: The Role of Gonadotropins in Alzheimer Pathogenesis
Webber, K. M., Casadesús, G., Marlatt, M. W., Perry, G. L., Hamlin, C. R., Atwood, C., Bowen, R. L., & Smith, M. A. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1347.020 · Cited by 50
Self-citationPerry, G. L., Richey, P. L., Siedlak, S. L., Smith, M. A., Mulvihill, P., DeWitt, D. A., Barnett, J. L., Greenberg, B. D., & Kalaria, R. N. (1993) · PubMed · Cited by 49
Self-citationAttenuation of the Neurotoxic Effect of Aβ Amyloid Peptide by Apolipoprotein E
Whitson, J. S., Mims, M. P., Strittmatter, W. J., Yamaki, T., Morrisett, J. D., & Appel, S. H. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.1209 · Cited by 49
Zandi, P. P. (2004) · Archives of Neurology · doi:10.1001/archneur.61.1.82 · Cited by 47
Murphy, G. M., Eng, L. F., Ellis, W. G., Perry, G. L., Meissner, L. C., & Tinklenberg, J. R. (1990) · Brain Research · doi:10.1016/0006-8993(90)90345-c · Cited by 46
A Possible Unitary Genetic Hypothesis for Alzheimer's Disease and Down Syndromea
Schweber, M. (1985) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1985.tb21495.x · Cited by 46
Tacrine, and Alzheimer's treatments*
Summers, W. K. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9s350 · Cited by 45
The Effect of Cholinesterase Inhibitors on the Secretion of APPS from Rat Brain Cortexa
GIACOBINI, E., MORI, F., & LAI, C. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb34451.x · Cited by 45
Kim, H., Tahara, K., Maxwell, J. A., Lalonde, R., Fukuiwa, T., Fujihashi, K., Kampen, K. R. V., Kong, F.-K., Tang, D.-C. C., & Fukuchi, K. (2007) · The Journal of Gene Medicine · doi:10.1002/jgm.993 · Cited by 45
Amyloid‐β: A vascular sealant that protects against hemorrhage?
Atwood, C. S., Bishop, G. M., Perry, G., & Smith, M. A. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10388 · Cited by 44
Self-citationChanging the Course of Alzheimer's Disease: Anti-Amyloid Disease-Modifying Treatments on the Horizon
Christensen, D. D. (2007) · The Primary Care Companion to The Journal of Clinical Psychiatry · doi:10.4088/pcc.v09n0106 · Cited by 44
Amyloid‐beta reduction by memapsin 2 (beta‐secretase) immunization
Chang, W., Downs, D., Huang, X., Da, H., Fung, K.-M. A., & Tang, J. (2007) · The FASEB Journal · doi:10.1096/fj.06-7993com · Cited by 43
Kamal, M. A., Klein, P., Yu, Q., Tweedie, D., Li, Y., Holloway, H. W., & Greig, N. H. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-10108 · Cited by 42
Kawai, M., Cras, P. P., & Perry, G. L. (1992) · Brain Research · doi:10.1016/0006-8993(92)91686-9 · Cited by 39
Hirano, A., & Zimmerman, H. M. (1962) · Archives of Neurology · doi:10.1001/archneur.1962.00450200028003 · Cited by 39
Trinh, N.-H., Hoblyn, J., Mohanty, S., & Yaffe, K. (2003) · JAMA · doi:10.1001/jama.289.2.210 · Cited by 37
Pollanen, M. S., Markiewicz, P., & Goh, M. C. (1997) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199701000-00008 · Cited by 33
Intravenous immunoglobulin and Alzheimer's disease immunotherapy.
Solomon, B. (2007) · PubMed · Cited by 32
Autopsy-Confirmed Familial Early-Onset Alzheimer Disease Caused by the L153V Presenilin 1 Mutation
Janssen, J. C., Lantos, P. L., Fox, N. C., Harvey, R. J., Beck, J. A., Dickinson, A., Campbell, T. A., Collinge, J., Hanger, D. P., Cipolotti, L., et al. (2001) · Archives of Neurology · doi:10.1001/archneur.58.6.953 · Cited by 27
Will antioxidants fulfill their expectations for the treatment of Alzheimer disease?
Rottkamp, C. A., Nunomura, A., Hirai, K., Sayre, L. M., Perry, G. L., & Smith, M. A. (2000) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(00)00124-x · Cited by 27
Self-citationGiannakopoulos, P., Gold, G., Duc, M., Michel, J., Hof, P. R., & Bouras, C. (2000) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017263 · Cited by 25
The pathogenesis of Alzheimer disease: an alternative to the amyloid hypothesis.
Ma, S., & Perry, G. L. (1997) · PubMed · Cited by 20
Biopsy Support for the Validity of Pittsburgh Compound B Positron Emission Tomography With a Twist
Klunk, W. E. (2008) · Archives of Neurology · doi:10.1001/archneur.65.10.1281 · Cited by 12
Aisen, P. S., Schafer, K. A., Grundman, M., Pfeiffer, E., Sano, M., Davis, K. L., Farlow, M. R., Jin, S., Thomas, R. G., Thal, L. J., et al. (2003) · JAMA · doi:10.1001/jama.289.21.2819 · Cited by 5
Kordower (1999) · doi:10.1002/1531-8249(199909)46:3
Zujovic (2000) · doi:10.1002/(sici)1098-1136(20000215)29:4
(1990) · PubMed Central
Cited by
Variant of TREM2 Associated with the Risk of Alzheimer's Disease
Jonsson, T., Stefansson, H., Steinberg, S., Jonsdottir, I., Jonsson, P. V., Snaedal, J., Bjornsson, S., Huttenlocher, J., Levey, A. I., Lah, J. J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211103 · Cited by 2,558
Mitochondrial dynamics in health and disease: mechanisms and potential targets
Chen, W., Zhao, H., & Li, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01547-9 · Cited by 1,306
Maternal immune activation and abnormal brain development across CNS disorders
Knuesel, I., Chicha, L., Britschgi, M., Schobel, S. A., Bodmer, M., Hellings, J. A., Toovey, S., & Prinssen, E. P. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.187 · Cited by 880
Epidemiology of Dementias and Alzheimer’s Disease
Sosa-Ortiz, A. L., Acosta-Castillo, I., & Prince, M. J. (2012) · Archives of Medical Research · doi:10.1016/j.arcmed.2012.11.003 · Cited by 553
New insights into the role of TREM2 in Alzheimer’s disease
Gratuze, M., Leyns, C. E. G., & Holtzman, D. M. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0298-9 · Cited by 489
Metadata
- Authors
- Castellani, R. J., Rolston, R. K., & Smith, M. A.
- Venue
- Disease-a-Month
- Publisher
- Elsevier BV
- Published
- 2010-09
- Volume
- 56
- Issue
- 9
- Pages
- 484-546
- ISSN
- 0011-5029 (ISSN-L)
- OpenAlex
- W4211208097
- Cited by
- 519
- References
- 296
- FWCI
- 15.41
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.